During this segment, the panelists conclude that although treatment guidelines are now being developed to help practitioners consider therapy options for patients with systemic lupus erythematosus (SLE), there are still factors that need to be addressed.
Michelle Petri, MD, MPH, explains that there are now 3 clinical practice guidelines for the treatment of lupus, whereas in the past there were none. The American College of Rheumatology, Systemic Lupus International Collaborating Clinics, and European League Against Rheumatism guidelines exhibit consistencies about how to treat patients with lupus.
However, Dr Petri explains that the guidelines need to address how to treat patients who fail suggested induction therapies. Dr Petri believes that flexibility is key due to the need to individualize therapy for patients in instances of poor outcomes.
Dr Petri feels that our country is still in the “dark ages” in regard to addressing the needs of patients with SLE. She explains that because SLE is a rare disease, there is still no FDA-approved gold standard for treating the disease.
Agreeing with Dr Petri, Maria Lopes, MD, MS, believes that there is a need for personalized therapy, which requires an in-depth, collaborative discussion about how to treat a patient as an individual before beginning therapy.
Enhancing Outpatient Hemophilia Care May Improve Health Outcomes and Costs
May 18th 2024Prospective data from patients attending a rural practice in West Virginia between 2016 and 2023 show that a quality improvement program that followed guideline recommendations and was tailored to specific patient needs reduced preventable bleeds and lowered costs.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen